Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: Protective effects of rapamycin

Free Radical Research

Volumn 46, Issue 8, 2012, Pages 1011-1018

  Siddiqui, Almas ^a   Hanson, Ingrid ^a   Andersen, Julie K ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Mitophagy; Monoamine oxidase B; MTOR; Oxidative stress; Parkin; Rapamycin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BETA ACTIN; PARKIN; RAPAMYCIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; AUTOPHAGY; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TOXICITY; MITOPHAGY; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSONISM; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

ANIMALS; AUTOPHAGY; CELL DIFFERENTIATION; CELL SURVIVAL; DOXYCYCLINE; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; MONOAMINE OXIDASE; NEURONS; OXIDATIVE STRESS; PC12 CELLS; PROTEIN TRANSPORT; RATS; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

PARKINSONIA;

EID: 84863888014     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.662277     Document Type: Article

References (25)

1. Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 2006;15:433-442.
2. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
3. Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996;55:259-272.
4. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 2010;12:119-131.
5. Hardy J, Cookson MR, Singleton A. Genes and parkinsonism. Lancet Neurol 2003;2:221-228.
6. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392:605-608.
7. Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol.Cell 2010;40:280-293.
8. Kumar MJ, Andersen JK. Perspectives on MAO-B in aging and neurological disease: where do we go from here? Mol Neurobiol 2004;30:77-89.
9. Kumar MJ, Nicholls DG, Andersen JK. Oxidative alphaketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implications for Parkinson's disease. J Biol Chem 2003;278:46432-46439.
10. Langston JW, Ballard PA Jr. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 1983;309:310.
11. Lavoie MJ, Cortese GP, Ostaszewski BL, Schlossmacher MG. The effects of oxidative stress on parkin and other E3 ligases. J Neurochem 2007;103:2354-2368.
12. Moore DJ. Parkin: a multifaceted ubiquitin ligase. Biochem Soc Trans 2006;34:749-753.
13. Olanow CW, McNaught KS. Ubiquitin-proteasome system and Parkinson's disease. Mov Disord 2006;21:1806-1823.
14. Pan T, Kondo S, Le W, Jankovic J. The role of autophagylysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008;131:1969-1978.
15. Qin ZH, Wang Y, Kegel KB, Kazantsev A, Apostol BL, Thompson LM, et al. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet 2003;12:3231-3244.
16. Ravikumar B, Berger Z, Vacher C, O'Kane CJ, Rubinsztein DC. Rapamycin pre-treatment protects against apoptosis. Hum Mol Genet 2006;15:1209-1216.
17. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001;293:263-269.
18. Siddiqui A, Mallajosyula JK, Rane A, Andersen JK. Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression. Neurobiol Dis 2010;40:444-448.
19. Sies H. Role of reactive oxygen species in biological processes. Klin Wochenschr 1991;69:965-968.
20. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M, et al. Alpha-synuclein in Lewy bodies. Nature 1997;388:839-840.
21. Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O, Whitworth AJ, et al. Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 2009;12:1129-1135.
22. Tanaka A. Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett 2010;584: 1386-1392.
23. Thomas B, Beal MF. Parkinson's disease. Hum Mol Genet 2007;16(Spec No. 2):R183-R194.
24. Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 1996;264:484-509.
25. Zid BM, Rogers AN, Katewa SD, Vargas MA, Kolipinski MC, Lu TA, et al. 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell 2009;139:149-160.